Table 3.

Correlations between Measures of Hepatic Steatosis (L:SAR and Liver Attenuation) and Inflammatory Markers and Lipoprotein Concentrations

	Model	Number	Spearman r	GEE-Adjusted P Value
log(serum C-reactive protein) to L:SAR	0	608	−0.1557	<0.0001
log(serum C-reactive protein) to L:SAR	2	608	−0.0946	0.004
log(serum C-reactive protein) to liver attenuation	0	608	−0.2224	<0.0001
log(serum C-reactive protein) to liver attenuation	2	608	−0.1398	0.0004
log(serum adiponectin) to L:SAR	0	588	0.357	<0.0001
log(serum adiponectin) to L:SAR	2	588	0.3372	<0.0001
log(serum adiponectin) to liver attenuation	0	588	0.292	<0.001
log(serum adiponectin) to liver attenuation	2	588	0.2852	<0.001
Total serum cholesterol to L:SAR	0	621	−0.0394	0.678
Total serum cholesterol to L:SAR	2	621	−0.0213	0.6863
Total serum cholesterol to liver attenuation	0	621	−0.0877	0.2286
Total serum cholesterol to liver attenuation	2	621	−0.0614	0.8569
log(serum triglycerides) to L:SAR	0	621	−0.3048	<0.0001
log(serum triglycerides) to L:SAR	2	621	−0.2454	<0.0001
log(serum triglycerides) to liver attenuation	0	621	−0.2632	<0.0001
log(serum triglycerides) to liver attenuation	2	621	−0.1869	<0.0001
Serum HDL to L:SAR	0	621	0.2543	<0.0001
Serum HDL to L:SAR	2	621	0.2055	<0.0001
Serum HDL to liver attenuation	0	621	0.1775	<0.0001
Serum HDL to liver attenuation	2	621	0.1374	<0.0001
Serum LDL to L:SAR	0	592	0.018	0.2069
Serum LDL to L:SAR	2	592	0.3336	0.1032
Serum LDL to liver attenuation	0	592	−0.0397	0.6734
Serum LDL to liver attenuation	2	592	−0.0280	0.4224

Model 0: Unadjusted.

Model 2: Adjusted for age, gender, race, diabetes status, and pack-years smoking history.